CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY/PARENT NET INVESTMENT - USD ($) $ in Thousands	Total	Total Common Stockholders’ Equity	Preferred Stock Series A	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Non-controlling Interest	Parent Net Investment	Class A Common Stock Common Stock	Class B Common Stock Common Stock
Balance at beginning of period (shares) at Dec. 31, 2016			0						0	0
Balance at beginning of period at Dec. 31, 2016	$ 65,220	$ 0	$ 0		$ 0	$ 0	$ 0	$ 65,220	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net distribution to parent	(2,267)							(2,267)
Net income (loss)	(11,948)	2,449				2,449	(18,811)	4,414
Stock issued during period (in shares)			95,000	4,900,776					588,276
Stock issued during period	90,780	20,186	$ 70,594		20,186
Proceeds and shares obtained in the Transaction (shares)									5,856,581	29,807,692
Proceeds and shares obtained in the Transaction	18,688	7,451			7,447		78,604	(67,367)	$ 1	$ 3
Distribution to noncontrolling interest, net	(38,106)						(38,106)
Benefit from reversal of valuation allowance	1,537	1,537			1,537
Restricted shares granted to directors and employee service awards (shares)									119,456
Stock-based compensation	1,245	1,245			1,245
Series A Preferred stock dividends (shares)			5,530
Series A Preferred stock dividends	(38)	(12,936)	$ 12,898		(10,487)	(2,449)
Series A Preferred stock conversion (shares)			(2,832)						246,262
Series A Preferred stock conversions		2,832	$ (2,832)		2,832
Series B Preferred Stock dividends, deemed dividends and return	(2,447)	(2,447)			(2,447)
Impact of transactions affecting noncontrolling interests		9,633			9,633		(9,633)
Balance at end of period (shares) at Dec. 31, 2017			97,698						6,222,299	29,807,692
Balance at end of period at Dec. 31, 2017	122,664	29,950	$ 80,660		29,946	0	12,054	$ 0	$ 1	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	117,962	58,036				58,036	59,926
Adjustment to deferred taxes	6,119	6,119			6,119
Stock issued during period (in shares)									6,990,744
Stock issued during period	39,356	39,356			39,356
Benefit from reversal of valuation allowance	2,912	2,912			2,912
Restricted stock issued (shares)									640,814
Restricted stock withheld for taxes (shares)									(93,721)
Restricted stock withheld for taxes	(749)	(749)			(749)
Stock-based compensation	6,477	6,477			6,477
Series A Preferred stock dividends (shares)			3,971
Series A Preferred stock dividends	(3,967)	(7,938)	$ 3,971			(7,938)
Series B Preferred Stock dividends, deemed dividends and return	(23,437)	(23,437)				(23,437)
Impact of transactions affecting noncontrolling interests		(41,790)			(41,790)		41,790
Balance at end of period (shares) at Dec. 31, 2018			101,669						13,760,136	29,807,692
Balance at end of period at Dec. 31, 2018	267,337	68,936	$ 84,631		42,271	26,661	113,770		$ 1	$ 3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(30,088)	8,415				8,415	(38,503)
Adjustment to deferred taxes	(7,741)	(7,741)			(7,741)
Additional paid-in-capital related to tax receivable agreement	5,573	5,573			5,573
Restricted stock issued (shares)									764,292
Restricted stock issued	1	1							$ 1
Restricted stock withheld for taxes (shares)									(69,902)
Restricted stock withheld for taxes	(246)	(246)			(246)
Stock-based compensation	6,124	6,124			6,124
Series A Preferred stock dividends (shares)			3,920
Series A Preferred stock dividends	(4,254)	(8,174)	$ 3,920		(2,006)	(6,168)
Series B Preferred Stock dividends, deemed dividends and return	(23,590)	(23,590)			(5,808)	(17,782)
Impact of transactions affecting noncontrolling interests	0	34,692			34,692		(34,692)
Exchange of Class B Common Stock to Class A Common Stock (in shares)									14,100,000	(14,100,000)
Exchange of Class B Common Stock to Class A Common Stock									$ 1	$ (1)
Balance at end of period (shares) at Dec. 31, 2019			105,589						28,554,526	15,707,692
Balance at end of period at Dec. 31, 2019	$ 213,116	$ 83,990	$ 88,551		$ 72,859	$ 11,126	$ 40,575		$ 3	$ 2